Covered recipient · General Payments record
CAISSON HOGUE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$3,497.36
- Reported across 213 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $468.61 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $191.28 | 12 |
| Supernus Pharmaceuticals, Inc. | $135.10 | 4 |
| Novo Nordisk AS | $28.78 | 2 |
| Amgen Inc. | $24.69 | 1 |
| Lilly USA, LLC | $24.36 | 1 |
| Abbott Laboratories | $19.72 | 1 |
| Astellas Pharma US Inc | $16.59 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.09 | 1 |
| PFIZER INC. | $14.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $19.72 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125065086 | CMS |
| ABBVIE INC. | $16.17 | 01/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103929024 | CMS |
| ABBVIE INC. | $16.70 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103929026 | CMS |
| ABBVIE INC. | $14.19 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103929028 | CMS |
| ABBVIE INC. | $11.55 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103929030 | CMS |
| ABBVIE INC. | $12.79 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103929032 | CMS |
| ABBVIE INC. | $15.78 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103929034 | CMS |
| ABBVIE INC. | $18.79 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103929036 | CMS |
| ABBVIE INC. | $16.87 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103929038 | CMS |
| ABBVIE INC. | $9.81 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103929040 | CMS |
| ABBVIE INC. | $28.88 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103929042 | CMS |
| ABBVIE INC. | $17.37 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103929044 | CMS |
| ABBVIE INC. | $12.38 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103929046 | CMS |
| Amgen Inc. | $24.69 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117279404 | CMS |
| Astellas Pharma US Inc | $16.59 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139299624 | CMS |
| Lilly USA, LLC | $24.36 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136086480 | CMS |
| Novartis Pharmaceuticals Corporation | $14.09 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086950797 | CMS |
| Novo Nordisk Inc | $15.59 | 02/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097037415 | CMS |
| Novo Nordisk Inc | $13.19 | 03/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097236243 | CMS |
| PFIZER INC. | $14.00 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131806481 | CMS |
| Supernus Pharmaceuticals, Inc. | $81.03 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147842287 | CMS |
| Supernus Pharmaceuticals, Inc. | $14.16 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147842285 | CMS |
| Supernus Pharmaceuticals, Inc. | $14.16 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147896021 | CMS |
| Supernus Pharmaceuticals, Inc. | $25.75 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147896023 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.